Spinal Manipulative Therapy for Low Back Pain
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00294229|
Recruitment Status : Completed
First Posted : February 20, 2006
Last Update Posted : October 3, 2011
Context: Acute low back pain (LBP) is a common reason for consultations in primary care. Reducing the pain in the first hours and days and restoring the functional capacity of the lumbar spine may result in a decrease in medical costs and earlier return to work.
Objective: To determine the impact of spinal manipulation on pain and analgesic use in acute low back pain.
|Condition or disease||Intervention/treatment||Phase|
|Low Back Pain||Procedure: manipulative therapy||Phase 4|
Design: Randomised controlled parallel-group trial comparing standard care plus spinal manipulative therapy with standard care alone. Intention-to-treat analysis.
Patients: Outpatients with acute low back pain. Setting: Emergency Department of Bern University Hospital and a primary care practice network.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||104 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Spinal Manipulative Therapy for Low Back Pain: Randomised Controlled Trial|
|Study Start Date :||March 2003|
|Actual Primary Completion Date :||April 2006|
|Actual Study Completion Date :||October 2006|
- Back pain overall measured by a numeric rating scale(range 0 to 10)
- Analgesic use based on daily equivalence doses (paracetamol, diclofenac and codeine)
- Roland Morris Score
- Serious adverse events
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00294229
|Department of Social and Preventive Medicine (ISPM), University of Bern|
|Bern, Switzerland, 3012|
|Principal Investigator:||Peter M. Villiger, MD||Dep. of Rheumatology & Clinical Immunology/Allergology, University Hospital of Berne|
|Study Director:||Peter Juni, MD||Department of Social and Preventive Medicine (ISPM), University of Berne|